ArticleBlood and lymphatic cancer : targets and therapy2024
Highly Curative Treatment of High-Risk Acute Promyelocytic Leukemia: Induction and Consolidation with ATRA+ATO+anthracyclines and Maintenance with ATRA+RIF.
Dan Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.